Paper40670830
Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review.
Mahooti M and 7 others. Inflammopharmacology, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review. Papers, record 40670830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40670830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Probiotics | Major topic |
| Neoplasms | Major topic |
| Inflammation | Major topic |
| Adjuvants, Immunologic | Major topic |
| Humans | |
| Animals | |
| Gastrointestinal Microbiome | |
| Cytokines |
Source PubMed
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35115705 | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. | Nat Med | 2022 | https://conductscience.org/library/papers/35115705 | PubMed |
| 2 | 33236974 | Probiotic Lactobacilli Enhance Immunogenicity of an Inactivated H9N2 Influenza Virus Vaccine in Chickens. | Viral Immunol | 2021 | https://conductscience.org/library/papers/33236974 | PubMed |
| 3 | 39435279 | The role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39435279 | PubMed |
| 4 | 26749362 | Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. | J Gastroenterol | 2016 | https://conductscience.org/library/papers/26749362 | PubMed |
| 5 | 27411589 | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27411589 | PubMed |
| 6 | 30523317 | The microbiome influence. | Nat Med | 2018 | https://conductscience.org/library/papers/30523317 | PubMed |
| 7 | 30530851 | Microbiota and cancer immunotherapy: in search of microbial signals. | Gut | 2019 | https://conductscience.org/library/papers/30530851 | PubMed |
| 8 | 30521105 | A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. | Cancer | 2019 | https://conductscience.org/library/papers/30521105 | PubMed |
| 9 | 34052844 | Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy. | Food Funct | 2021 | https://conductscience.org/library/papers/34052844 | PubMed |
| 10 | 33764387 | Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/33764387 | PubMed |
| 11 | 37637950 | Remarkable impacts of probiotics supplementation in enhancing of the antioxidant status: results of an umbrella meta-analysis. | Front Nutr | 2023 | https://conductscience.org/library/papers/37637950 | PubMed |
| 12 | 29232932 | Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. | Vaccines (Basel) | 2017 | https://conductscience.org/library/papers/29232932 | PubMed |
| 13 | 39475254 | Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea. | mSystems | 2024 | https://conductscience.org/library/papers/39475254 | PubMed |
| 14 | 34926547 | Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients-A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial. | Front Nutr | 2021 | https://conductscience.org/library/papers/34926547 | PubMed |
| 15 | 36307808 | Antioxidants in brain tumors: current therapeutic significance and future prospects. | Mol Cancer | 2022 | https://conductscience.org/library/papers/36307808 | PubMed |
| 16 | 38944216 | Application of probiotics in cervical cancer infections to enhance the immune response. | Microb Pathog | 2024 | https://conductscience.org/library/papers/38944216 | PubMed |
| 17 | 24487531 | H(2)O(2) production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase. | Appl Environ Microbiol | 2014 | https://conductscience.org/library/papers/24487531 | PubMed |
| 18 | 29636538 | The gut microbiota influences anticancer immunosurveillance and general health. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29636538 | PubMed |
| 19 | 26311717 | Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. | Gut | 2016 | https://conductscience.org/library/papers/26311717 | PubMed |
| 20 | 24976724 | Emerging roles of lactic acid bacteria in protection against colorectal cancer. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24976724 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42201634 | Efficacy of Probiotics and Postbiotics in Treating Dengue Fever - A Potential Strategy to Reduce Antibody-dependent Enhancement. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42201634 | PubMed |
| 41149079 | Application and Challenges of Using Probiotic Lactobacillus and Bifidobacterium to Enhance Overall Health and Manage Diseases. | Diseases | 2025 | https://conductscience.org/library/papers/41149079 | PubMed |
| 41134485 | The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41134485 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40670830
GET https://conductscience.org/api/papers/v1/40670830/references?page=2